Zobrazeno 1 - 10 of 26 pro vyhledávání: '"D M C Brinkman"'
1
Akademický článek
No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis
Autor: P. C. E. Hissink Muller, W. G. van Braak, D. Schreurs, C. M. Nusman, S. A. Bergstra, R. Hemke, D. Schonenberg-Meinema, J. M. van den Berg, T. W. Kuijpers, Y. Koopman-Keemink, M. A. J. van Rossum, L. W. A. van Suijlekom-Smit, D. M. C. Brinkman, C. F. Allaart, R. ten Cate, M. Maas
Publikováno v: Pediatric Rheumatology Online Journal, Vol 17, Iss 1, Pp 1-10 (2019)
Abstract Background To evaluate radiographic progression of patients with new-onset juvenile idiopathic arthritis (JIA) in response to an early, tightly-controlled, treatment-to-target. Methods Patients with JIA participating in the BeSt-for-Kids-stu
Externí odkaz: https://doaj.org/article/9f6b8856c2614c5e9188951408c5eb83
Zobrazit plný text záznamu
2
No radiographic wrist damage after treatment to target in recent-onset juvenile idiopathic arthritis
Autor: Cornelia F Allaart, Charlotte M. Nusman, Taco W. Kuijpers, D. M. C. Brinkman, R. ten Cate, P. C. E. Hissink Muller, M. A. J. van Rossum, Y. Koopman-Keemink, D. Schonenberg-Meinema, L.W.A. van Suijlekom-Smit, Sytske Anne Bergstra, J.M. van den Berg, W. G. van Braak, D. Schreurs, Mario Maas, Robert Hemke
Publikováno v: Pediatric rheumatology online journal, 17(1):62. BioMed Central
Pediatric Rheumatology, 17(1):62. BioMed Central Ltd.
Pediatric Rheumatology, 17(1)
Pediatric Rheumatology Online Journal
Pediatric Rheumatology. Springer
Pediatric Rheumatology
Pediatric Rheumatology Online Journal, Vol 17, Iss 1, Pp 1-10 (2019)
Background To evaluate radiographic progression of patients with new-onset juvenile idiopathic arthritis (JIA) in response to an early, tightly-controlled, treatment-to-target. Methods Patients with JIA participating in the BeSt-for-Kids-study, rando
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df08556d1c1667be39320201b6879d89
https://doi.org/10.1186/s12969-019-0362-1
Zobrazit plný text záznamu
3
POS1300 PAIN IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS TREATED TO TARGET: 24 MONTH RESULTS FROM A RANDOMISED TRIAL
Autor: Y. Koopman-Keemink, J.M. van den Berg, K. Spekking, Cornelia F Allaart, P. C. E. Hissink Muller, D. M. C. Brinkman, M. A. J. van Rossum, L.W.A. van Suijlekom-Smit, R. ten Cate, Sytske Anne Bergstra, P. De Boer, D. Schonenberg-Meinema
Publikováno v: Annals of the Rheumatic Diseases. 80:932.1-932
Background:Juvenile Idiopathic Arthritis (JIA) is the most common auto-immune disease in children and pain is a common symptom. Despite treatment advances in recent years, pain often persists when the disease is inactive. Treating JIA to target has b
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::afd196c77e0502d0dc83689be23a52e8
https://doi.org/10.1136/annrheumdis-2021-eular.988
Zobrazit plný text záznamu
5
A comparison of three treatment strategies in recent onset non-systemic Juvenile Idiopathic Arthritis : Initial 3-months results of the BeSt for Kids-study
Autor: R. ten Cate, M. A. J. van Rossum, J.M. van den Berg, L.W.A. van Suijlekom-Smit, P. C. E. Hissink Muller, I. C. J. Brederije, D. M. C. Brinkman, W. P. Bekkering, Y. Koopman-Keemink, Taco W. Kuijpers, D. Schonenberg, Cornelia F Allaart
Publikováno v: Pediatric Rheumatology, 15(1). BioMed Central
Pediatric Rheumatology Online Journal
Pediatric Rheumatology
Pediatric Rheumatology, 15:11. BioMed Central Ltd.
Pediatric rheumatology online journal, 15(1). BioMed Central
Pediatric Rheumatology, 15
Combination therapy with prednisone or etanercept may induce earlier and/or more improvement in disease activity in Disease Modifying Anti Rheumatic Drug (DMARD) naive non-systemic Juvenile Idiopathic Arthritis (JIA) patients. Here we present three m
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c5877b335547755d27ba8be98b5ca00
https://dspace.library.uu.nl/handle/1874/349179
Zobrazit plný text záznamu
6
Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis
Autor: Judith A.M. Wessels, R.J.H.M. van der Straaten, L. W. A. Suijlekom-Smit, Carine Wouters, Henk-Jan Guchelaar, S. le Cessie, HJ Girschick, R. ten Cate, D. M. C. Brinkman, HM Albers, Marco W. Schilham, Sylvia Kamphuis, Twj Huizinga
Publikováno v: Arthritis & Rheumatism, 61(1), 46-51. John Wiley & Sons Ltd.
Pediatric Rheumatology Online Journal
Objective Methotrexate (MTX) is the most commonly used disease-modifying antirheumatic drug in juvenile idiopathic arthritis (JIA). Currently, individual response to MTX cannot be reliably predicted. Identification of clinical and genetic factors tha
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c780fa5dfb8a130a007eff7194678c4a
https://doi.org/10.1002/art.24087
Zobrazit plný text záznamu
7
Current perspectives of autologous stem cell transplantation for severe juvenile idiopathic arthritis
Autor: NM Wulffraat, D. M. C. Brinkman, E. M. van Rooijen, R. Tewarie, Berent J. Prakken, Wietse Kuis
Publikováno v: Autoimmunity. 41:632-638
The majority of children with Juvenile Idiopathic Arthritis can nowadays be treated adequately. However despite the use of combinations of antirheumatic drugs, corticosteroids and the newer so called biologicals (blocking the TNF, Interleukin 1 or In
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa3e02d215a4bdd88dbf15b7fa2d8621
https://doi.org/10.1080/08916930802200224
Zobrazit plný text záznamu
8
Resetting the Adaptive Immune System After Autologous Stem Cell Transplantation: Lessons from Responses to Vaccines
Autor: C.M. Jol-van der Zijde, P. A. W. te Boekhorst, NM Wulffraat, Jaak M. Vossen, R. ten Cate, Rogier Q. Hintzen, M.J.D. van Tol, M. M. ten Dam, D. M. C. Brinkman
Publikováno v: Journal of Clinical Immunology
Journal of Clinical Immunology, 27(6), 647-658. Springer New York
Autologous stem cell transplantation (ASCT) to treat autoimmune diseases (AID) is thought to reset immunological memory directed against autoantigens. This hypothesis can only be studied indirectly because the exact nature of the pathogenetic autoant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84935176456d7a1316989bffe017d64a
http://europepmc.org/articles/PMC2075528
Zobrazit plný text záznamu
9
CD226 (DNAM-1) is associated with susceptibility to juvenile idiopathic arthritis
Autor: Rotraud K. Saurenmann, Jeanine J. Houwing-Duistermaat, R. ten Cate, HM Albers, Esther P A H Hoppenreijs, Twj Huizinga, E Bakker, Willem Verduijn, D. M. C. Brinkman, Carine Wouters, T H C M Reinards, Anne Hinks, Sylvia Kamphuis, P.E. Slagboom, M. A. J. van Rossum, Justine A. Ellis, René E. M. Toes, Hermann J. Girschick, Marco W. Schilham
Publikováno v: Annals of the Rheumatic Diseases, 74, 12, pp. 2193-8
Annals of the Rheumatic Diseases, 74, 2193-8
Annals of the Rheumatic Diseases, 74(12), 2193-2198. BMJ Publishing Group
Annals of the Rheumatic Diseases, 74(12), 2193-2198
Europe PubMed Central
Annals of the rheumatic diseases, 74(12), 2193-2198. BMJ Publishing Group
Annals of the Rheumatic Diseases
ObjectivesJuvenile idiopathic arthritis (JIA) is considered a complex genetic autoimmune disease. We investigated the association of genetic variants previously implicated in JIA, autoimmunity and/or immunoregulation, with susceptibility to JIA.Metho
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8302c2a804444ef9580b0d143e9e3153
https://hdl.handle.net/1887/106883
Zobrazit plný text záznamu
10
Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients
Autor: R. ten Cate, T H C M Reinards, E W N Levarht, Marieke H Otten, René E. M. Toes, Jing Shi, Esther P A H Hoppenreijs, P. C. E. Hissink Muller, Sylvia Kamphuis, Leendert A. Trouw, J.M. van den Berg, J. Anink, C.M. Jol-van der Zijde, M. A. J. van Rossum, Koert M. Dolman, Marco W. Schilham, M.J.D. van Tol, Tom W J Huizinga, L.W.A. van Suijlekom-Smit, Cornelia F Allaart, D. M. C. Brinkman, Y. Koopman-Keemink
Publikováno v: Annals of the Rheumatic Diseases, 72, 12, pp. 2053-5
Annals of the Rheumatic Diseases, 72(12), 2053-2055
Annals of the Rheumatic Diseases; Vol 72
Annals of the Rheumatic Diseases, 72(12), 2053-2055. BMJ Publishing Group
Annals of the Rheumatic Diseases
Annals of the rheumatic diseases, 72(12), 2053-2055. BMJ Publishing Group
Annals of the Rheumatic Diseases, 72, 2053-5
In juvenile idiopathic arthritis (JIA) patients there is a lack of markers that predict severe disease. Although anticitrullinated protein antibodies (ACPA) have contributed substantially to the understanding of rheumatoid arthritis (RA),1 their dete
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4173ba924af7cfddbb729e94cd60d267
https://doi.org/10.1136/annrheumdis-2013-203650
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje